Literature DB >> 32056037

Management and new strategy of ovarian clear cell carcinoma.

Aikou Okamoto1.   

Abstract

Entities:  

Year:  2020        PMID： 32056037     DOI： 10.1007/s10147-020-01626-9

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


× No keyword cloud information.
  2 in total

1.  OSI-906 restores the sensitivity of ovarian clear cell carcinoma to cisplatin by targeting the IGF1R/AKT pathway.

Authors:  Li Liu; Changyan Liang; Chenya Zhuo; Huiyun Jiang; Huixia Ye; Tianyuan Ruan; Jiao Song; Senwei Jiang; Yu Zhang; Xiaomao Li
Journal:  Med Oncol       Date:  2022-01-04       Impact factor: 3.064

2.  Changes in SLIT2 expression are associated with the migration of human ovarian clear cell carcinoma cells.

Authors:  Cuei-Jyuan Lin; Way-Ren Huang; Chia-Zhen Wu; Ruo-Chia Tseng
Journal:  Oncol Lett       Date:  2021-05-24       Impact factor: 2.967
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.